# Dan Bi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dan-bi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,533 |
| Field | Cervical Cancer and HPV Research |
| h-index | 26 |
| i10-index | 40 |
| Last Known Institution | Beijing University of Technology |
| OpenAlex ID | https://openalex.org/A5013002476 |
| ORCID iD | 0000-0003-0426-4639 |
| Works | 86 |

## Researcher papers

- [Application of AI and IoT in Clinical Medicine: Summary and Challenges](https://scholariq.org/papers/application-of-ai-and-iot-in-clinical-medicine-summary-and-challenges/)
- [Isorhamnetin, A Flavonol Aglycone from<i>Ginkgo biloba</i>L., Induces Neuronal Differentiation of Cultured PC12 Cells: Potentiating the Effect of Nerve Growth Factor](https://scholariq.org/papers/isorhamnetin-a-flavonol-aglycone-from-i-ginkgo-biloba-i-l-induces-neuronal/)
- [Efficacy, immunogenicity and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial](https://scholariq.org/papers/efficacy-immunogenicity-and-safety-of-the-hpv-16-18-as04-adjuvanted-vaccine-in/)
- [The immune response after hypoxia-ischemia in a mouse model of preterm brain injury](https://scholariq.org/papers/the-immune-response-after-hypoxia-ischemia-in-a-mouse-model-of-preterm-brain/)
- [Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials](https://scholariq.org/papers/evaluation-of-type-replacement-following-hpv16-18-vaccination-pooled-analysis-of/)
- [The association between sex-related interleukin-6 gene polymorphisms and the risk for cerebral palsy](https://scholariq.org/papers/the-association-between-sex-related-interleukin-6-gene-polymorphisms-and-the/)
- [A novel protein derived from lamprey supraneural body tissue with efficient cytocidal actions against tumor cells](https://scholariq.org/papers/a-novel-protein-derived-from-lamprey-supraneural-body-tissue-with-efficient/)
- [Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial](https://scholariq.org/papers/characteristics-of-a-cluster-randomized-phase-iv-human-papillomavirus/)
- [Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial](https://scholariq.org/papers/efficacy-immunogenicity-and-safety-of-the-as04-hpv-16-18-vaccine-in-chinese/)
- [Immunogenicity and safety of human papillomavirus‐16/18 AS04‐adjuvanted cervical cancer vaccine in healthy Indian women](https://scholariq.org/papers/immunogenicity-and-safety-of-human-papillomavirus-16-18-as04-adjuvanted-cervical/)
- [Caregivers' burden and its influencing factors among parents of children with asthma and comorbidities: a cross-sectional study](https://scholariq.org/papers/caregivers-burden-and-its-influencing-factors-among-parents-of-children-with/)

## Researcher topics

- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Cerebral Palsy and Movement Disorders](https://scholariq.org/topics/cerebral-palsy-and-movement-disorders/)
- [Neonatal and fetal brain pathology](https://scholariq.org/topics/neonatal-and-fetal-brain-pathology/)
- [Immune Response and Inflammation](https://scholariq.org/topics/immune-response-and-inflammation/)

## Researcher university

- [Beijing University of Technology](https://scholariq.org/institutions/beijing-university-of-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.